CN1355882A - 定量转化生长因子-β1的方法以及通过使用该方法检测癌症的方法 - Google Patents
定量转化生长因子-β1的方法以及通过使用该方法检测癌症的方法 Download PDFInfo
- Publication number
- CN1355882A CN1355882A CN 00806081 CN00806081A CN1355882A CN 1355882 A CN1355882 A CN 1355882A CN 00806081 CN00806081 CN 00806081 CN 00806081 A CN00806081 A CN 00806081A CN 1355882 A CN1355882 A CN 1355882A
- Authority
- CN
- China
- Prior art keywords
- tgf
- special
- antibody
- cancer
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1999/12568 | 1999-04-09 | ||
KR19990012568 | 1999-04-09 | ||
KR19990043935 | 1999-10-12 | ||
KR1999/43935 | 1999-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1355882A true CN1355882A (zh) | 2002-06-26 |
Family
ID=26634921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 00806081 Pending CN1355882A (zh) | 1999-04-09 | 2000-04-10 | 定量转化生长因子-β1的方法以及通过使用该方法检测癌症的方法 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1166112A4 (id) |
JP (1) | JP2002541479A (id) |
CN (1) | CN1355882A (id) |
AU (1) | AU768029B2 (id) |
BR (1) | BR0009607A (id) |
CA (1) | CA2369892A1 (id) |
ID (1) | ID30316A (id) |
MX (1) | MXPA01009942A (id) |
NZ (1) | NZ514596A (id) |
TR (1) | TR200102917T2 (id) |
WO (1) | WO2000062062A1 (id) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2430257A1 (en) * | 2000-11-28 | 2002-06-06 | Amgen, Inc. | Transforming growth factor-beta-related molecules and uses thereof |
JP4834835B2 (ja) * | 2006-07-27 | 2011-12-14 | 国立大学法人浜松医科大学 | 自閉症の診断薬 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59195162A (ja) * | 1983-04-21 | 1984-11-06 | Toyo Jozo Co Ltd | トランスホ−ミンググロスフアクタ−の検定用試薬 |
JPS59216058A (ja) * | 1983-05-23 | 1984-12-06 | Toyo Jozo Co Ltd | トランスホ−ミンググロスフアクタ−の定量法 |
JPS59226864A (ja) * | 1983-06-07 | 1984-12-20 | Toyo Jozo Co Ltd | トランスホ−ミンググロスファクタ−の酵素免疫測定法 |
JPS6018764A (ja) * | 1983-07-12 | 1985-01-30 | Toyo Jozo Co Ltd | トランスホ−ミンググロスフアクタ−の免疫測定法 |
JPH02126157A (ja) * | 1988-11-04 | 1990-05-15 | Tosoh Corp | ヒトトランスフォーミンググロースファクターβの免疫学的測定方法 |
WO1993010215A1 (en) * | 1991-11-15 | 1993-05-27 | Memorial Sloan-Kettering Cancer Center | Purified proteoglycan betaglycan, compositions, and methods |
GB9601081D0 (en) * | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
-
2000
- 2000-04-10 ID IDW00200102145A patent/ID30316A/id unknown
- 2000-04-10 CN CN 00806081 patent/CN1355882A/zh active Pending
- 2000-04-10 NZ NZ514596A patent/NZ514596A/xx unknown
- 2000-04-10 MX MXPA01009942A patent/MXPA01009942A/es unknown
- 2000-04-10 AU AU41471/00A patent/AU768029B2/en not_active Ceased
- 2000-04-10 EP EP00921123A patent/EP1166112A4/en not_active Withdrawn
- 2000-04-10 TR TR2001/02917T patent/TR200102917T2/xx unknown
- 2000-04-10 WO PCT/KR2000/000329 patent/WO2000062062A1/en not_active Application Discontinuation
- 2000-04-10 JP JP2000611074A patent/JP2002541479A/ja active Pending
- 2000-04-10 BR BR0009607-5A patent/BR0009607A/pt not_active IP Right Cessation
- 2000-04-10 CA CA002369892A patent/CA2369892A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2369892A1 (en) | 2000-10-19 |
MXPA01009942A (es) | 2003-07-14 |
EP1166112A1 (en) | 2002-01-02 |
WO2000062062A1 (en) | 2000-10-19 |
BR0009607A (pt) | 2002-01-08 |
NZ514596A (en) | 2003-03-28 |
EP1166112A4 (en) | 2004-11-10 |
AU768029B2 (en) | 2003-11-27 |
JP2002541479A (ja) | 2002-12-03 |
ID30316A (id) | 2001-11-22 |
TR200102917T2 (tr) | 2002-03-21 |
AU4147100A (en) | 2000-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110144009A (zh) | Cd47单域抗体及其用途 | |
US20170240651A1 (en) | Agr2 blocking antibody and use thereof | |
CN113138276B (zh) | 用于检测HBcAg的方法及抗体 | |
CN106188281B (zh) | 抗诺如病毒gii.4型鼠源单克隆抗体的制备和应用 | |
TR201911272T4 (tr) | Paliperidon haptenleri. | |
CN112980803B (zh) | 抗vim型碳青霉烯酶杂交瘤细胞株,单克隆抗体及应用 | |
CN102459340A (zh) | 粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体 | |
CN107880130A (zh) | 一种具有高亲和力的抗癌胚抗原纳米抗体及应用 | |
CN108997499A (zh) | 一种抗人pd-l1抗体及其应用 | |
CN113717283A (zh) | 一种抗乙型肝炎病毒e抗原的单克隆抗体及其应用 | |
CN115925867A (zh) | 一种肿瘤标志物单克隆抗体及其应用 | |
CN114409780A (zh) | 一种磷酸化Tau pT181蛋白单克隆抗体、ELISA试剂盒及其应用 | |
CN106188282A (zh) | 抗诺如病毒gi.1型鼠源单克隆抗体的制备和应用 | |
WO2024140618A1 (zh) | 1,3-β-D-葡聚糖结合蛋白、制备方法及应用 | |
CN109142738A (zh) | Ecm1作为血清学检测肝纤维化的标志物及其应用 | |
CN113045666B (zh) | 胃蛋白酶原ii单克隆抗体及其应用 | |
CN113150138B (zh) | 一种kpc-2单克隆抗体及其制备方法和应用 | |
CN110317270A (zh) | 抗毒蛇pla2蛋白抗体及其应用 | |
CN108997500A (zh) | 一种抗人pd-l1抗体及其应用 | |
CN107108722A (zh) | 针对粘蛋白4(muc4)糖肽的抗体及其用途 | |
CN110702913A (zh) | 一种用于定量检测贝氏柯克斯体i相株的单抗组合物 | |
CN1355882A (zh) | 定量转化生长因子-β1的方法以及通过使用该方法检测癌症的方法 | |
EP3656794A1 (en) | Composition and methods for detecting cancer | |
CN109880805A (zh) | 抗隐球菌荚膜多糖单克隆抗体及其杂交瘤细胞株制备与应用 | |
CN113150139B (zh) | 一种PBP2a单克隆抗体及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |